Taken together, our results demonstrated that TTF might inhibit GBM cell metastasis through decreased EMT and ECM marker expression, via downregulation of the NF-κB, MAPK and PI3K/AKT signaling pathways (Figure 6). Here, AKT1 is linked to glioblastoma.